ReShape Lifesciences
Price & Volume
Stats
See more52W Range | $4.60-$23.20 |
Market Cap | $3.6M |
Shares Short | 25,009 |
Financials
See moreRevenue (12 Mos) | $8M |
Revenue Growth (YoY) | -12.8% |
Gross Profit (12 Mos) | $6.8M |
Diluted EPS | $76.20 |
News
See moreYahoo Finance • last year
ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds
Yahoo Finance • last year
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction Plan
Yahoo Finance • last year
ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate Update
Yahoo Finance • last year
ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering
About
CEO | Mr. Paul F. Hickey |
CFO | Mr. Thomas Stankovich |
Address | 18 Technology Drive, Irvine, CA, United States, 92618 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 29 |
